Evidence map›Paper›PMID 37333195›Full record

ArticleResearch square2023

Applying RE-AIM to examine the impact of an implementation facilitation package to scale up a program for Veterans with Chronic Obstructive Pulmonary Disease.

Edward C Portillo, Martha A Maurer, Jordyn T Kettner, Sonia D Bhardwaj, Ziting Zhang, Cassie Sedgwick, Aaron M Gilson, Jamie A Stone, Nora Jacobson, Rose Hennessy-Garza and 4 more

Open access · greenAbstract readPreprint
In one paragraph

Article in Research square, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Edward C PortilloUniversity of Wisconsin-Madison School of Pharmacy.
Martha A MaurerUniversity of Wisconsin-Madison School of Pharmacy.ORCID 0000-0001-7404-8881
Jordyn T KettnerUniversity of Wisconsin-Madison School of Pharmacy.
Sonia D BhardwajUniversity of Wisconsin-Madison School of Pharmacy.
Ziting ZhangUniversity of Wisconsin-Madison School of Pharmacy.
Cassie SedgwickVA Medical Center Madison: William S Middleton Memorial Veterans Hospital.
Aaron M GilsonUniversity of Wisconsin-Madison School of Pharmacy.
Jamie A StoneUniversity of Wisconsin-Madison School of Pharmacy.
Nora JacobsonUniversity of Wisconsin-Madison Institute for Clinical and Translational Reserach.
Rose Hennessy-GarzaUWM Joseph J Zilber School of Public Health: University of Wisconsin-Milwaukee Joseph J Zilber School of Public Health.
Sarah WillDepartment of Veterans Affairs Pharmacy Benefits Management Clinical Pharmacy Practice Office.
M Shawn McFarlandDepartment of Veterans Affairs Pharmacy Benefits Management Clinical Pharmacy Practice Office.
Heather OurthDepartment of Veterans Affairs Pharmacy Benefits Management Clinical Pharmacy Practice Office.
Michelle A ChuiUniversity of Wisconsin-Madison School of Pharmacy.
University of Wisconsin–Madison · USWilliam S. Middleton Memorial Veterans Hospital · US

Funding

University of Wisconsin Institute for Clinical and Translational ResearchUL1TR002373 · NCATS · UNIVERSITY OF WISCONSIN-MADISON · PI ELIZABETH S BURNSIDE, Allan R. Brasier · 2017 to 2026
$75.9M
Institutional Career Development CoreKL2TR002374 · NCATS · UNIVERSITY OF WISCONSIN-MADISON · PI Bo Liu, Marin Leigh Schweizer · 2017 to 2026
$9.7M
NCATS NIH HHS KL2 TR002374NCATS NIH HHS UL1 TR002373
6 · The paper itself

Abstract

Background: U.S. Veterans are four-times more likely to be diagnosed with Chronic Obstructive Pulmonary Disease (COPD) compared to the civilian population with no care model that consistently improves Veteran outcomes when scaled. COPD Coordinated Access to Reduce Exacerbations (CARE) is a care bundle intended to improve the delivery of evidence-based practices to Veterans. To address challenges to scaling this program in the Veterans' Health Administration (VA), the COPD CARE Academy (Academy), an implementation facilitation package comprised of four implementation strategies was designed and implemented. Methods: This evaluation utilized a mixed-methods approach to assess the impact of the Academy's implementation strategies on the RE-AIM framework implementation outcomes and the extent to which they were effective at increasing clinicians' perceived capability to implement COPD CARE. A survey was administered one week after Academy participation and a semi-structured interview conducted eight to 12 months later. Descriptive statistics were calculated for quantitative items and thematic analysis was used to analyze open-ended items. Results: Thirty-six clinicians from 13 VA medical centers (VAMCs) participated in the Academy in 2020 and 2021 and 264 front-line clinicians completed COPD CARE training. Adoption of the Academy was indicated by high rates of Academy completion (97%), session attendance (90%), and high utilization of Academy resources. Clinicians reported the Academy to be acceptable and appropriate as an implementation package and clinicians from 92% of VAMCs reported long-term utilization of Academy resources. Effectiveness of the Academy was represented by clinicians' significant increases (p < 0.05) in their capability to complete ten implementation tasks after Academy participation. Conclusions: This evaluation found that the use of implementation facilitation paired with additional strategies seemed to demonstrate positive implementation outcomes across all RE-AIM domains and identified areas for potential improvement. Future assessments are needed to explore post-academy resources that would help VAMCs to strategize localized approaches to overcome barriers.

Indexed as

Chronic Obstructive Pulmonary Diseaseimplementation facilitationRE-AIMVeterans Healthcare Administration

Identifiers

PMID37333195
PMCPMC10275052
OpenAlexW4379880113

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.